Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study.

Paulo M PitrezRodrigo G de SouzaCristian RoncadaJoao P Heinzmann-FilhoGiovana SantosLeonardo A PintoMarcus H JonesRenato T Stein

Published in: Pediatric pulmonology (2017)

In this retrospective report, the use of omalizumab in Brazilian children with STRA significantly improved disease control, decreased hospitalizations, and allowed suspension of continuous oral corticosteroids.

Keyphrases

young adults
chronic obstructive pulmonary disease
physical activity
mental health
early onset
stem cells
cystic fibrosis
drug induced